Impact of maternal Body Mass Index on IVF outcome
DOI:
https://doi.org/10.56056/amj.2025.370Keywords:
Body mass index, Follicular stimulating hormone, In vitro fertilization, Luteinizing hormoneAbstract
Background and objectives: Obesity is a rapidly developing health issue all over the world. Excess body fat causes menstruation abnormalities, particularly chronic oligo-anovulation, as well as infertility. The aim of the current research is to review the impact of women’s weight on the outcome of the in vitro fertilization treatment.
Methods: A retrospective single center cohort study was conducted with 129 women undergoing in vitro fertilization cycles from 2022–2023 at Erbil maternity teaching hospital in vitro fertilizaton center. One-hundred-twenty-nine women undergoing assisted reproductive therapy were recruited for the purpose of this study. The target age range of patients was 18-43 years. The study focused on the effect of body mass index on infertility, hormonal status and outcome of in vitro fertilization.
Results: In the normal weight category, there were 18 women (14%), whereas the overweight category comprised 57 individuals (44.1%), and the obese category included 54 participants (41.9%). Primary infertility was observed in 88.9% of the women with normal body mass index, 73.7% and 74.1% of the overweight and obese women respectively. Conversely, secondary infertility was identified in 11.1% of the women with normal body mass index, 26.3% and 25.9% of the overweight and obese women respectively (p>0.05). Regarding pregnancy rates, they stood at 16.7% for the women with normal body mass index, 17.5% for the overweight and 29.6% for obese women (p>0.05).
Conclusion: The findings in our study suggests no relationship between obesity on hormonal levels or clinical pregnancy outcomes.
Downloads
References
1. Sathya A, Balasubramanyam S, Gupta S, Verma T. Effect of body mass index on in vitro fertilization outcomes in women. J Hum Reprod Sci. 2010;3(3):135-8. doi:10.4103/0974-1208.74155/
2. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief. 2020; 360:1–8.
3. Snider AP, Wood JR. Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction. 2019;158(3): R79–R90. doi: 10.1530/REP-18-0583/
4. Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):439–51. doi: 10.1093/humupd/dmz011/
5. Song J, Xiang S, Pang C, Guo J, Sun Z. Metabolomic alternations of follicular fluid of obese women undergoing in-vitro fertilization treatment. Sci Rep. 2020;10(1):5968. doi: 10.1038/s41598-020-62975-z/
6. Ruebel ML, Piccolo BD, Mercer KE, Pack L, Moutos D, Shankar K, et al. Obesity leads to distinct metabolomic signatures in follicular fluid of women undergoing in vitro fertilization. Am J Physiol Endocrinol Metab. 2019;316(3):E383–E396. doi: 10.1152/ajpendo.00401.2018/
7. Ruebel ML, Cotter M, Sims CR, Moutos DM, Badger TM, Cleves MA, et al. Obesity modulates inflammation and lipid metabolism oocyte gene expression: a single-cell transcriptome perspective. J Clin Endocrinol Metab. 2017;102(6):2029–38. doi: 10.1210/jc.2016-3524/
8. Comstock IA, Diaz-Gimeno P, Cabanillas S, Bellver J, Sebastian-Leon P et al. Does an increased body mass index affect endometrial gene expression patterns in infertile patients? A functional genomics analysis. Fertil Steril. 2017;107(3):740–8. e2. doi: 10.1016/j.fertnstert.2016.11.009/
9. Pagliassotti MJ, Kim PY, Estrada AL, Stewart CM, Gentile CL. Endoplasmic reticulum stress in obesity and obesity-related disorders: an expanded view. Metabolism. 2016;65(9):1238–46. doi: 10.1016/j.metabol.2016.05.002/
10. Breininger SP, Malcomson FC, Afshar S, Turnbull DM, Greaves L, Mathers JC. Effects of obesity and weight loss on mitochondrial structure and function and implications for colorectal cancer risk. Proc Nutr Soc. 2019;78(3):426–37. doi: 10.1017/S0029665119000533/
11. Lin YC, Chang SY, Lan KC, Huang HW, Chang CY, Tsai MY, et al. Human oocyte maturity in vivo determines the outcome of blastocyst developmentin vitro. J Assist Reprod Genet. 2003; 20:506–12.
12. Gardner DK, Weissman A, Howles CM. Repeated implantation failure. Textbook of Assisted Reproductive Technologies. 4th Ed. Florida: Informa healthcare; 2012: 214–5.
13. Centers for Disease Control and Prevention. Defining Adult Overweight & Obesity: Adult Body Mass Index. Available from: https://www.cdc.gov/obesity/basics/adult-defining.html/
14. Norman RJ, Noakes M, Wu R. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update. 2004; 10:267–80.
15. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology- a systematic review. Hum Reprod Update. 2007; 13:433–44.
16. Fedorscak P, Dale PO, Storeng R. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod. 2004; 19:2523–8.
17. Bellver J, Ayllón Y, Ferrando M, Melo M, Goyri E, Pellicer A, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93(2):447-54. doi: 10.1016/j.fertnstert.2008.12.032/
18. Supramaniam PR, Mittal M, McVeigh E, Lim LN. The correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence. Reprod Health. 2018;15(1):34. doi:10.1186/s12978-018-0481-z/
19. Zargar AH, Wani AI, Masoodi SR, Laway BA, Salahuddin M. Epidemiologic and etiologic aspects of primary infertility in the Kashmir region of India. Fertil Steril. 1997;68(4):637–43.
20. Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update. 2008;14(5):415–29.
21. Dhandapani K, Kodavanji B, Vinodini NA. Association of body mass index with primary and secondary infertility among infertile women in Mangalore: A cross-sectional study. Natl J Physiol Pharm Pharmacol 2016; 6:81-4.
22. Buyuk E, Seifer DB, Illions E, Grazi RV, Lieman H. Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil Steril. 2011;95(7):2364-68. doi: 10.1016/j.fertnstert.2011.03.081/
23. Thomas MC, Sadek S, Banks N. Effect of BMI on serum Estradiol levels and correlation with pregnancy outcomes in programmed frozen embryo transfer cycles. Fertil Steril. 2022;118(5): E56.
24. Shen Z, Luo X, Xu J, Jiang Y, Chen W, et al. Effect of BMI on the value of serum progesterone to predict clinical pregnancy outcome in IVF/ICSI cycles: a retrospective cohort study. Front Endocrinol (Lausanne). 2023; 14:1162302. doi:10.3389/fendo.2023.1162302/
25. Van Dam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frölich M, Meinders AE et al. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am J Physiol Endocrinol Metab. 2002;282(4): E865-E872. doi:10.1152/ajpendo.00458.2001/
26. Liu X, Shi S, Sun J, He Y, Zhang Z, Xing J, et al. The influence of male and female overweight/obesity on IVF outcomes: a cohort study based on registration in Western China. Reprod Health. 2023;2;20(1):3. doi: 10.1186/s12978-022-01558-9/
27. Nichols JE, Crane MM, Higdon HL. Extremes of body mass index reduce in vitro fertilization rates. Fertil Steril. 2003; 79:645–7.
28. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res. 2002; 10:551–4.
29. Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23(4):421-39. doi: 10.1016/j.rbmo.2011.06.018/
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dehat Salah Qadir, Awat Ibrahim Hamadamin, Lava Talat Sharief
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
